Avondale Partners Downgrades Allscripts (MDRX) Two Notches to 'Underperform'
Tweet
Share
E-mailGet Alerts MDRX Hot Sheet
Price: $5.00 -2.72%
Rating Summary:
8 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 66
Rating Summary:
8 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 66
Join SI Premium – FREE
Avondale Partners downgraded Allscripts (NASDAQ: MDRX) from Market Outperform to Underperform with a price target of $7.00.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $16.02 yesterday.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $16.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Downgrades Capricor Therapeutics (CAPR) to Neutral
- Stephens Downgrades BioLife Solutions (BLFS) to Equal Weight
- TD Cowen Downgrades Forte Biosciences Inc. (FBRX) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Avondale PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
